Medical Transcription Billing Corp (MTBC) CFO Bill Korn Sells 9,664 Shares

Medical Transcription Billing Corp (NASDAQ:MTBC) CFO Bill Korn sold 9,664 shares of the stock in a transaction dated Wednesday, November 7th. The shares were sold at an average price of $5.52, for a total transaction of $53,345.28. Following the completion of the transaction, the chief financial officer now owns 167,750 shares of the company’s stock, valued at approximately $925,980. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Bill Korn also recently made the following trade(s):

  • On Monday, November 5th, Bill Korn sold 3,800 shares of Medical Transcription Billing stock. The shares were sold at an average price of $5.51, for a total transaction of $20,938.00.

NASDAQ MTBC traded down $0.12 on Thursday, reaching $5.11. The company’s stock had a trading volume of 959 shares, compared to its average volume of 83,952. Medical Transcription Billing Corp has a twelve month low of $2.11 and a twelve month high of $5.65. The company has a market capitalization of $64.56 million, a price-to-earnings ratio of -39.23 and a beta of 1.58.

Medical Transcription Billing (NASDAQ:MTBC) last issued its quarterly earnings results on Wednesday, November 7th. The technology company reported ($0.25) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.23) by ($0.02). Medical Transcription Billing had a negative net margin of 2.73% and a positive return on equity of 2.01%. The business had revenue of $17.05 million during the quarter, compared to analyst estimates of $16.66 million. On average, sell-side analysts anticipate that Medical Transcription Billing Corp will post -0.5 EPS for the current year.

A hedge fund recently bought a new stake in Medical Transcription Billing stock. Dimensional Fund Advisors LP purchased a new stake in Medical Transcription Billing Corp (NASDAQ:MTBC) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 27,909 shares of the technology company’s stock, valued at approximately $108,000. Dimensional Fund Advisors LP owned about 0.24% of Medical Transcription Billing at the end of the most recent quarter. 5.93% of the stock is currently owned by hedge funds and other institutional investors.

Separately, HC Wainwright set a $6.00 price target on shares of Medical Transcription Billing and gave the company a “buy” rating in a report on Thursday. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Medical Transcription Billing has an average rating of “Buy” and a consensus price target of $3.92.

ILLEGAL ACTIVITY WARNING: This news story was reported by WKRB News and is the sole property of of WKRB News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at

About Medical Transcription Billing

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Recommended Story: How Do I Invest in Dividend Stocks

Insider Buying and Selling by Quarter for Medical Transcription Billing (NASDAQ:MTBC)

Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with's FREE daily email newsletter.

Leave a Reply